PEMGX
Price
$37.13
Change
-$0.55 (-1.46%)
Updated
Jun 3 closing price
Net Assets
24.29B
TIAGX
Price
$19.76
Change
+$0.08 (+0.41%)
Updated
Jun 3 closing price
Net Assets
167.22M
Interact to see
Advertisement

PEMGX vs TIAGX

Header iconPEMGX vs TIAGX Comparison
Open Charts PEMGX vs TIAGXBanner chart's image
PEMGX vs TIAGX Comparison Chart in %
View a ticker or compare two or three
VS
PEMGX vs. TIAGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Buy and TIAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 24.3B vs. TIAGX (167M). PEMGX (0.00) and TIAGX (0.00) have matching dividends . PEMGX was incepted earlier than TIAGX: PEMGX (21 years) vs TIAGX (13 years). TIAGX (1.46) is less costly to investors than PEMGX (0.90). TIAGX is a more actively managed with annual turnover of: 74.00 vs. PEMGX (13.70). PEMGX has a lower initial minimum investment than TIAGX: PEMGX (1000) vs TIAGX (100000). TIAGX annual gain was more profitable for investors over the last year : 57.82 vs. PEMGX (-14.13). TIAGX return over 5 years is better than : 65.08 vs. PEMGX (-2.51).
PEMGXTIAGXPEMGX / TIAGX
Total Expense Ratio0.901.3666%
Annual Report Gross Expense Ratio0.901.4662%
Fund Existence21 years13 years-
Gain YTD-7.48836.762-20%
Front Load6%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets24.3B167M14,551%
Annual Yield % from dividends0.000.00-
Returns for 1 year-14.1357.82-24%
Returns for 3 years14.8899.4015%
Returns for 5 years-2.5165.08-4%
Returns for 10 years76.07191.4540%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPLIX30.53N/A
N/A
Voya Index Plus LargeCap Port I
DEMZX67.17N/A
N/A
Nomura Emerging Markets R6
TLVCX15.43N/A
N/A
Timothy Plan Large/Mid Cap Value C
TEMQX16.62N/A
N/A
Franklin Mutual Quest C
SRFMX12.29N/A
N/A
Sarofim Equity